CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

2141 v-11

mAbexperimental

Clinical trial activity

6 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Aug 19, 2019 (NCT04059588)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2024

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06455605Phase 1Nov 1, 2024Duke University, Rockefeller University
NCT06347705Phase 2Mar 28, 2024Memorial Sloan-Kettering Cancer Center
NCT05734560Phase 1/Phase 2 (Phase 2)Sep 6, 2023Duke University, Rockefeller University
NCT05126472Phase 1Nov 8, 2021Memorial Sloan-Kettering Cancer Center, Pin Down Bladder Cancer Research Foundation, Rockefeller University
NCT04547777Phase 1Dec 31, 2020Duke University, Rockefeller University
NCT04059588Phase 1Aug 19, 2019Rockefeller University
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Rockefeller UniversityAcademic/Hospital5122019
Duke UniversityAcademic/Hospital3322020
Memorial Sloan-Kettering Cancer CenterAcademic/Hospital2222021
Pin Down Bladder Cancer Research FoundationAcademic/Hospital1012021
4 organizations
Page 1 / 1